5/5 - (1 vote)

MedVi vs Hims: Compare GLP-1 Programs & Pricing

Side-by-side MedVi and Hims: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

MedVi and Hims are two established telehealth providers offering GLP-1–based weight management programs. This article compares MedVi vs Hims to help you identify which best fits your goals and preferences.

Visit MedVi
Explore Hims

MedVi vs Hims: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
MedVi	$179.00	$279.00	$120 off first month (Code: )	— No
Hims				—

MedVi vs Hims: Medical Process & Accessibility

MedVi focuses on a streamlined telehealth intake that includes a brief health questionnaire, virtual clinician review, and rapid prescription issuance. Once approved, a licensed U.S. pharmacy compounds the medication and ships it directly to your door. Hims follows a similar virtual pathway but adds scheduled follow‑up video visits to fine‑tune dosage and monitor side effects over time. Both services are fully virtual, comply with FDA‑approved prescribing standards, and require a valid prescription from a U.S.‑licensed clinician.

Start with MedVi

MedVi vs Hims: Pricing Comparison

MedVi starts semaglutide at $179.00 and tirzepatide at $279.00. Hims does not currently list GLP‑1 pricing on its public site, so a direct price comparison is not available at this time. Because MedVi provides the only disclosed lower price, it is highlighted in bold for quick reference.

Both platforms may offer promotional discounts. MedVi advertises “$120 off first month” (no promo code required). Hims does not list a current promotion, so prospective users should check the Hims website for any seasonal offers.

Compare Hims Pricing

MedVi vs Hims: Clinical Oversight & Support

Both providers give patients direct access to board‑certified physicians or nurse practitioners who are authorized to prescribe GLP‑1 medications. MedVi’s model is oriented toward quick approval for patients who have already completed a basic health screen. Hims emphasizes ongoing clinical support, offering regular check‑ins to adjust dose, address side effects, and provide lifestyle coaching.

Book a Consultation with MedVi

MedVi vs Hims: Medication Quality & Safety

Each provider partners with accredited U.S. compounding pharmacies that follow Good Manufacturing Practices (GMP). While the compounds are not the brand‑name Wegovy® or Mounjaro®, they contain the same active ingredients (semaglutide or tirzepatide) at FDA‑approved dosages. Prescriptions are only filled after a qualified clinician verifies that the medication is appropriate for the patient’s medical history, weight, and any contraindications.

MedVi vs Hims: Customer Experience

Patient reviews often cite MedVi’s affordability and rapid shipping as major strengths. Users appreciate the simple questionnaire and the ability to start treatment within days of approval. Hims receives praise for its comprehensive follow‑up program, responsive care team, and educational resources on nutrition and exercise. Both companies report average delivery times of 5‑7 business days after prescription approval.

Explore Hims Reviews

MedVi vs Hims: Final Verdict

If low upfront cost and fast onboarding are your top priorities, MedVi is the clear choice. For patients who value ongoing clinician interaction, dose optimization, and a more structured support system, Hims may be the better fit. Both services operate under U.S. telehealth regulations, partner with licensed pharmacies, and adhere to FDA prescribing guidelines, ensuring safe access to GLP‑1 therapy.

Join MedVi
Get Started with Hims

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice